<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0194867</article-id>
<article-id pub-id-type="publisher-id">PONE-D-17-36888</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Digestive system</subject><subj-group><subject>Gastrointestinal tract</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Digestive system</subject><subj-group><subject>Gastrointestinal tract</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical compounds</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Vitamins</subject><subj-group><subject>Vitamin D</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Organic chemistry</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Vitamins</subject><subj-group><subject>Vitamin D</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Hormones</subject><subj-group><subject>Lipid hormones</subject><subj-group><subject>Calcitriol</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Blood cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>Monocytes</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>Monocytes</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>Monocytes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>Monocytes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune response</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune response</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune physiology</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune physiology</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune system</subject><subj-group><subject>Innate immune system</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune system</subject><subj-group><subject>Innate immune system</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Developmental biology</subject><subj-group><subject>Molecular development</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Hepatocytes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Liver</subject><subj-group><subject>Hepatocytes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Liver</subject><subj-group><subject>Hepatocytes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Anatomical pathology</subject><subj-group><subject>Cytopathology</subject><subj-group><subject>Steatosis</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model</article-title>
<alt-title alt-title-type="running-head">Chronic calcitriol supplementation improves intestinal/adipose tissue alternation in steatohepatitis rats</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Su</surname>
<given-names>Yen-Bo</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Li</surname>
<given-names>Tzu-Hao</given-names>
</name>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Huang</surname>
<given-names>Chia-Chang</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Tsai</surname>
<given-names>Hung-Cheng</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Huang</surname>
<given-names>Shiang-Fen</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Hsieh</surname>
<given-names>Yun-Cheng</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2919-9853</contrib-id>
<name name-style="western">
<surname>Yang</surname>
<given-names>Ying-Ying</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
<xref ref-type="aff" rid="aff008"><sup>8</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Huang</surname>
<given-names>Yi-Hsiang</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Hou</surname>
<given-names>Ming-Chih</given-names>
</name>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Lin</surname>
<given-names>Han-Chieh</given-names>
</name>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Division of Allergy and Immunology, Taipei Veterans General Hospital, Taipei, Taiwan</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>Chia-Yi Branch of Taichung Veterans General Hospital, Chiayi, Taiwan</addr-line></aff>
<aff id="aff006"><label>6</label> <addr-line>Division of Infection, Taipei Veterans General Hospital, Taipei, Taiwan</addr-line></aff>
<aff id="aff007"><label>7</label> <addr-line>Division of Gastroenterology and Hepatology, Taipei Veterans General Hospital, Taipei, Taiwan</addr-line></aff>
<aff id="aff008"><label>8</label> <addr-line>Division of General Medicine, Taipei Veterans General Hospital, Taipei, Taiwan</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Gracia-Sancho</surname>
<given-names>Jordi</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>IDIBAPS Biomedical Research Institute, SPAIN</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">yangyy@vghtpe.gov.tw</email> (YYY); <email xlink:type="simple">hclin@vghtpe.gov.tw</email> (HCL)</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>13</volume>
<issue>4</issue>
<elocation-id>e0194867</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>10</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>3</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-year>2018</copyright-year>
<copyright-holder>Su et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0194867"/>
<abstract>
<p>Vitamin D deficiency and up-regulated TNFα-related signals are reported to be involved in abnormalities including intestinal hyper-permeability, bacterial translocation, systemic/portal endotoxemia, intestinal/adipose tissue/hepatic inflammation, and hepatic steatosis in nonalcoholic steatohepatitis (NASH). This study aims to explore the molecular mechanisms and effects of chronic calcitriol [1,25-(OH)<sub>2</sub>D<sub>3</sub>, hormonal form of vitamin D] on gut-adipose tissue-liver axis abnormalities using a high-fat diet (HFD)-fed rat model of NASH. In HFD-fed obese rats on a 10-week calcitriol (0.3 μg/kg/TIW) or vehicle treatment (NASH-vit. D and NASH-V rats) reigme, various <italic>in vivo</italic> and <italic>in vitro</italic> experiments were undertaken. Through anti-TNFα-TNFR1-NFκB signaling effects, chronic calcitriol treatment significantly restored plasma calcitriol levels and significantly improved vitamin D receptor (VDR) expression in monocytes and the small intestine of NASH-vit. D rats. Significantly, plasma and portal endotoxin/TNFα levels, bacterial translocation to mesenteric lymph nodes, plasma DX-4000-FITC, fecal albumin-assessed intestinal hyper-permeability, over-expression of TNFα-related immune profiles in monocytes, inflammation of intestinal/mesenteric adipose tissue (MAT)/liver and hepatic steatosis were improved by chronic calcitriol treatment of NASH rats. Additionally, <italic>in vitro</italic> experiments with acute calcitriol co-incubation reversed NASH-V rat monocyte supernatant/TNFα-induced monolayer barrier dysfunction in caco-2 cells, cytokine release from MAT-derived adipocytes, and triglyceride synthesis by lean-V rat hepatocytes. Using <italic>in vivo</italic> and <italic>in vitro</italic> experiments, our study reported calcitriol signaling in the gut as well as in adipose tissue. Meanwhile, our study suggests that restoration of systemic and intestinal vitamin D deficiency using by chronic vitamin D treatment effectively reduces TNFα-mediated immunological abnormalities associated with the gut-adipose tissue-liver axis and hepatic steatosis in NASH rats.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001868</institution-id>
<institution>National Science Council</institution>
</institution-wrap>
</funding-source>
<award-id>NSC-102-2314-B-010-036-MY3</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2919-9853</contrib-id>
<name name-style="western">
<surname>Yang</surname>
<given-names>Ying-Ying</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution>Taipei Veteran General Hospital</institution>
</funding-source>
<award-id>V106EA-007</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2919-9853</contrib-id>
<name name-style="western">
<surname>Yang</surname>
<given-names>Ying-Ying</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>We especially thank Yun-Ru Wang, Fan-Yi Jhan, Che-Jui Chang and Yen-Ling Lin for their excellent technical supports. This work was entirely supported by research grants NSC-102-2314-B-010-036-MY3 and from the National Science Council, and V106EA-007, VGHUST105-GI-2-2 and by the Taipei Veterans General Hospital.</funding-statement>
</funding-group>
<counts>
<fig-count count="6"/>
<table-count count="3"/>
<page-count count="17"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files (<xref ref-type="supplementary-material" rid="pone.0194867.s005">S3 File</xref>).</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Higher levels of plasma and intestinal lipopolysaccharide (LPS, also called endotoxin) are noted in nonalcoholic steatohepatitis (NASH) patients than in healthy subjects [<xref ref-type="bibr" rid="pone.0194867.ref001">1</xref>,<xref ref-type="bibr" rid="pone.0194867.ref002">2</xref>]. LPS is the main stimulator to induce tumor necrosis factor-α (TNFα) release from immune cells [<xref ref-type="bibr" rid="pone.0194867.ref001">1</xref>]. Compared to healthy controls, significantly high LPS-stimulated TNFα production is observed in cultured whole blood cells from NASH patients [<xref ref-type="bibr" rid="pone.0194867.ref002">2</xref>]. In NASH, increased TNFα can exacerbate intestinal inflammation and mucosal barrier disruption [<xref ref-type="bibr" rid="pone.0194867.ref003">3</xref>–<xref ref-type="bibr" rid="pone.0194867.ref005">5</xref>]. In the inflamed intestinal epithelium, TNFα produced from infiltrated immune cells further results in systemic/portal inflammation and endotoxemia [<xref ref-type="bibr" rid="pone.0194867.ref003">3</xref>–<xref ref-type="bibr" rid="pone.0194867.ref006">6</xref>]. So, NASH is characterized by remarkable intestinal hyper-permeability, epithelial tight junctions disruption and endotoxemia [<xref ref-type="bibr" rid="pone.0194867.ref005">5</xref>,<xref ref-type="bibr" rid="pone.0194867.ref007">7</xref>].</p>
<p>In obese animals, intestinal dysbiosis is associated with increased macrophage infiltration and high cytokine release by mesenteric adipose tissue (MAT), which is positioned near the intestine and is drained by the portal vein [<xref ref-type="bibr" rid="pone.0194867.ref008">8</xref>]. Additionally, intestinal hyper-permeability and MAT inflammation are involved in the pathogenesis of portal endotoxemia and hepatic steatosis [<xref ref-type="bibr" rid="pone.0194867.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0194867.ref010">10</xref>]. Chronic intestinal/MAT inflammation and a disrupted intestinal barrier result in bacterial translocation and the progression of NAFLD to NASH [<xref ref-type="bibr" rid="pone.0194867.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0194867.ref011">11</xref>,<xref ref-type="bibr" rid="pone.0194867.ref012">12</xref>]. Notably, in NASH, intestinal hyper-permeability, systemic/portal endotoxemia, and systemic/intestinal/MAT inflammation are initiated by TNFα-released from activated immune cells [<xref ref-type="bibr" rid="pone.0194867.ref002">2</xref>,<xref ref-type="bibr" rid="pone.0194867.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0194867.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0194867.ref007">7</xref>,<xref ref-type="bibr" rid="pone.0194867.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0194867.ref010">10</xref>]. So, anti-TNFα agents have the potential to simultaneously ameliorate the aforementioned abnormalities in NASH [<xref ref-type="bibr" rid="pone.0194867.ref009">9</xref>,<xref ref-type="bibr" rid="pone.0194867.ref010">10</xref>, <xref ref-type="bibr" rid="pone.0194867.ref013">13</xref>,<xref ref-type="bibr" rid="pone.0194867.ref014">14</xref>].</p>
<p>In cultured human peripheral blood monocytes, 1,25-(OH)<sub>2</sub>D<sub>3</sub>, the hormonal form of vitamin D, is able to dose-dependently inhibit LPS-stimulated TNFα production [<xref ref-type="bibr" rid="pone.0194867.ref015">15</xref>]. Serum TNFα levels are negatively correlated with serum vitamin D concentrations in healthy women [<xref ref-type="bibr" rid="pone.0194867.ref016">16</xref>]. Among NASH patients, low serum vitamin D concentrations are closely associated with severe hepatic steatosis and inflammation [<xref ref-type="bibr" rid="pone.0194867.ref017">17</xref>]. Vitamin D receptor (VDR) is a nuclear receptor that mediates most of the known functions of vitamin D, including its anti-TNFα effects. Chronic mucosal inflammation and TNFα-induced down-regulation of gut epithelial VDR can be observed in cases of inflammatory bowel disease [<xref ref-type="bibr" rid="pone.0194867.ref018">18</xref>]. Through direct epithelial VDR up-regulation and indirect TNFα inhibition, vitamin D analog displays mucosal protection and anti-inflammatory effects [<xref ref-type="bibr" rid="pone.0194867.ref019">19</xref>].</p>
<p>Through histological evaluation in rat livers, vitamin D treatment from 6- weeks (time point for diet-induced NASH) to 12- weeks (time point for diet-induced fibrosis) after diet feeding has been found to prevent the progression of NASH to hepatic fibrosis [<xref ref-type="bibr" rid="pone.0194867.ref020">20</xref>]. With histological and gene expression measurements, depletion of vitamin D in a westernized diet exacerbates NAFLD through the activation of toll-like receptor (TLR) in NASH rat livers [<xref ref-type="bibr" rid="pone.0194867.ref021">21</xref>]. In addition to prevent the progression of NASH, vitamin D treatment reduced the serum free fatty acid/triglyceride levels, hepatic thiobarbituric acid-reactive substances (TBARS) levels, and hepatocyte apoptosis in rats [<xref ref-type="bibr" rid="pone.0194867.ref022">22</xref>]. Besides reducing hepatic steatosis, supplementation of vitamin D in the diet alleviates high-fat diet (HFD)-induced overweight and hyperinsulinemia by up-regulating hepatic lipolytic genes and adipose-tissue energy expenditure genes expressions in mice [<xref ref-type="bibr" rid="pone.0194867.ref023">23</xref>]. Especially in adipose tissue of obese rats, depletion of vitamin D in diet exacerbated HFD-increased adipose size by up-regulation of lipogenic/inflammatory genes and macrophage infiltration [<xref ref-type="bibr" rid="pone.0194867.ref024">24</xref>]. Further study reported that vitamin D treatment reduces hepatic triglyceride levels, hepatic nonalcoholic fatty liver disease activity score, and hepatic CD68/TGFβ1/αSMA expression, as well as decreases the levels of serum asparate aminotransferase and alanine aminotransferase in NASH rats [<xref ref-type="bibr" rid="pone.0194867.ref025">25</xref>]. Significantly, vitamin D treatment up-regulates nutrition sensing genes expression in adipose tissue of HFD-fed diabetic mice [<xref ref-type="bibr" rid="pone.0194867.ref026">26</xref>]. Chronic administration of vitamin D-enriched mushroom extracts reduces HFD-induced body fat accumulation, hepatic inflammation/steatosis (by histology and EchoMRI) and serum triglyceride/cytokine levels in mice [<xref ref-type="bibr" rid="pone.0194867.ref027">27</xref>].</p>
<p>To summarize the abovementioned studies [<xref ref-type="bibr" rid="pone.0194867.ref020">20</xref>–<xref ref-type="bibr" rid="pone.0194867.ref027">27</xref>], the therapeutic potential-associated with the anti-hepatic steatosis effects of vitamin D in the parallel abnormalities in circulation and the intestinal and adipose tissue of NASH animals have not been fully explored.</p>
<p>Accordingly, the present study aimed to evaluate the molecular mechanisms and effects of chronic vitamin D treatment on the aforementioned gut-adipose tissue-liver axis abnormalities using a rat model of diet-induced NASH.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec003">
<title>Animals</title>
<p>Male Sprague-Dawley (SD) rats (4-week old) were purchased from Charles River Japan, Inc. (Yokohama, Japan) and caged at 22°C on a 12-hour light-dark cycle with free access to water. Normal-chow-diet (NCD, Laboratory Autoclavable Rodent Diet 5010) or high-fat-diet (HFD, D12492) were given for 14 weeks to form the lean or NASH groups. From 4 to 14 weeks after NCD/HFD feeding, lean rats (Lean-V/lean-vit.D, n = 6 in each group) and NASH rats (NASH-V/NASH-vit.D, n = 9 in each group) received 10- weeks of either vehicle or 0.3 μg/kg/TIW of 1,25(OH)<sub>2</sub>D<sub>3</sub> by gastric gavage.</p>
<p>This study was approved by the Animal Experiments Committee of Yang-Ming University and was performed according to the “Guide for the care and use of laboratory animals” prepared by the National Academy of Science, USA and the ARRIVE guidelines [<xref ref-type="bibr" rid="pone.0194867.ref028">28</xref>]. All efforts were made to minimize animal numbers necessary to produce reliable results and suffering was reduced by administering anesthetics (zoletil and xylocaine). At the end of the experiments, the rats were euthanized with 2–3 times the anesthetic dose of zoletil.</p>
</sec>
<sec id="sec004" sec-type="materials|methods">
<title>Experimental design</title>
<p>Three days before the following experiments, <italic>in vivo</italic> intestinal permeability was measured in all rats. Subsequently, heparinized portal vein and whole-body blood was collected to separate peripheral blood mononuclear cells (PBMCs). Meanwhile, the liver, the intestine [doudenum, ileum, cecum and colon], mesenteric fats [the fat surrounding the gastrointestinal tract from the gastroesophageal sphincter to the end of the rectum], and the mesenteric lymph nodes [MLN, drained LNs from the terminal ileum, cecum and ascending colon] were collected by aseptic dissected. The macrophage numbers in the intestine and MAT were measured by flow cytometry. Primary monocytes (CD14<sup>+</sup>cells) were isolated from PBMCs and adipocytes were isolated from MAT.</p>
<p>In order to assess the <italic>in vitro</italic> effects of 1,25(OH)<sub>2</sub>D<sub>3</sub> on TNFα and NASH-CM-induced cascades, the intestinal epithelial caco-2 cells and lean-V rat hepatocytes were cultured with/without different concentrations of 1,25(OH)<sub>2</sub>D<sub>3</sub> [10<sup>−11</sup>, 10<sup>−9</sup>, 10<sup>-7</sup>M].</p>
</sec>
<sec id="sec005">
<title>Intestinal permeability</title>
<p>This measurement was based on the intestinal permeability to 4,000-Da fluorescent-dextran [DX-4000-fluorescein isothiocyanate (FITC), FD4000; Sigma-Aldrich, St. Louis, MO] by the analysis of time-dependent serum DX-4000-FITC concentration curves and area under curves (AUCs) [<xref ref-type="bibr" rid="pone.0194867.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0194867.ref006">6</xref>,<xref ref-type="bibr" rid="pone.0194867.ref008">8</xref>]. For validation, the intestinal permeability was re-assessed by measurement of albumin content in the rat feces using ELISA kits (MyBioSource, Inc, San Diego, California, USA).</p>
</sec>
<sec id="sec006">
<title>Measurements of cytokines/cytokines receptors in PBMC-derived monocytes</title>
<p>After intestinal permeability measurement, heparinized-blood was collected from all rats for PBMCs (25–30×10<sup>6</sup>) isolation. PBMCs suspensions were depleted of neutrophils, NK cells, T-cells, and B-cells using immuno-magnetic sorting beads for magnetic cell sorting (MACS) by negative selection with Ly6G-biotin, CD56-biotin, CD3-biotin, and CD19-biotin antibodies. Further, primary rat monocytes (CD14<sup>+</sup> cells) were isolated from above mentioned cell suspension as the CD14-biotin-positive, Ly6G/CD56/CD3/CD19-negative fraction separated by anti-CD14 mAb-coupled magnetic beads (Miltenyi Biotech, Bergisch Gladbach, Germany) through an MACS positive selection column. For flow cytometry analysis, monocytes (1 x 10<sup>6</sup>/ml/well) were fixed with 4% paraformaldehyde and permeabilized with 0.5% Triton X-100. Dead cells were then stained with propidium iodide (BD Biosciences) whereas live cells (monocyte) were stained, gated, and quantified for CD14/VDR,CD14/TNFα, CD14/NFκB,CD14/TNFRI and CD14/TNFRII double positive cells.</p>
<p>Monocytes were incubated for 20 h and cell free supernatants were harvested to measure TNFα, IL-6 and MCP-1 levels using ELISA kits (R&amp;D, Minneapolis, MN). The supernatants of 48-hour-cultured NASH-V rat monocytes were used as conditioned medium (NASH-V-CM) to evaluate it effect on caco-2 cell monolayer integrity, lean-V rat adipocyte cytokine release and lean-V rat hepatocytes steatosis.</p>
</sec>
<sec id="sec007">
<title>Plasma cytokines/chemokines level</title>
<p>Plasma glucose, asparatate aminotransferase (AST), alanine aminotransferase (ALT), and triglyceride levels were measured using a standard auto SMAC analyzer (Roche Diagnostics Gmbh, ANNHEIM, Germany). Using pyrogen-free water (Lonza, Basel, Switzerland) and a pyrogen-free container, portal vein/plasma endotoxin, TNFα and LPS-binding protein (LBP), plasma/intestine calcitriol [1,25(OH)<sub>2</sub>D<sub>3</sub>] were measured using ToxinSensor Chromogenic LAL Endotoxin Assay Kit (GenScript USA Inc.) and cytokines/calcitriol ELISA Kits (R&amp;D Systems INC., Minneapolis, MN). TG content in liver homogenate was measured by a TG Colorimetric Assay Kit (Cayman Chemical Company, Ann Arbor, MI, USA).</p>
</sec>
<sec id="sec008">
<title>Various intestinal and mesenteric adipose tissues (MAT) markers</title>
<p>Intestinal caspase-3 activity was determined. The protein and <italic>mRNA</italic> levels in the rat intestine, rat MAT-derived adipocytes, caco-2 cells, and rat hepatocytes were measured using appropriate antibodies and primers (<xref ref-type="supplementary-material" rid="pone.0194867.s001">S1 Table</xref>). For flow cytometry analysis, red blood cells (RBCs) present in 1 gram of intestinal and MAT homogenate were lysed using Pharm Lyse (BD Biosciences); the remaining cells (3×10<sup>6</sup> cells/gram tissue) were suspended in PBS containing 2mM EDTA and exposed to FcBLOCK (BD Biosciences) for 20 minutes. To indentify macrophage infiltration (×10<sup>3</sup>/gram tissue) in tissues, the cells (3×10<sup>5</sup> cells) were then labeled with FITC-conjugated F4/80 and PE-conjugated CD11b antibodies for quantification of CD11b(+)F4/80(+) cells by flow cytometry using a FACSalibur analyzer (BD Biosciences), whereas dead cells were identified using propidium iodide (BD Biosciences).</p>
</sec>
<sec id="sec009">
<title>Histological examination</title>
<p>NAFLD activity scores (NASs) were evaluated for rat liver samples. Duodenal tissue samples were used for immunohistochemical (IHC) studies of TNFα, TNFRI, and active caspase-7 expression.</p>
</sec>
<sec id="sec010">
<title>Bacterial translocation (BT) and fecal analysis</title>
<p>BT was defined as positivity of a bacterial culture in sterilized liquefied LMN. Three stool pellets (one per day) from each rat were pooled, dried and stored at 80°C to allow DNA extraction for quantification of the total number of bacterial cells, including intestinal <italic>Lactobacillus</italic> spp., <italic>Bifidobacterium</italic> spp. and <italic>Bacteroides-Prevotella</italic> spp.</p>
</sec>
<sec id="sec011">
<title>NASH-V-CM/TNFα-stimulated cytokines release from rat MAT-derived adipocytes</title>
<p>Lean-V and NASH-V adipocytes were isolated from rat MATs to measure time-dependent cytokine release [<xref ref-type="bibr" rid="pone.0194867.ref029">29</xref>]. Next, cytokines/cytokine receptor levels in the supernatant and <italic>mRNA</italic>s levels in the cell lysates of lean-V rat adipocytes treated with incremental concentration of 1,25(OH)<sub>2</sub>D<sub>3</sub>-treated were measured after stimulation with either TNFα or NASH-V-CM.</p>
</sec>
<sec id="sec012">
<title><italic>In vitro</italic> effects of calcitriol on NASH-V-CM/TNFα-induced caco-2 cell monolayer barrier dysfunction</title>
<p>Differentiated caco-2 monolayer cells (5×10<sup>5</sup>) were treated with buffer, TNFα, or NASH-V-CM. Subsequently, 1,25(OH)<sub>2</sub>D<sub>3</sub> was applied or was not to the apical and basolateral compartments for 48 hours. Next, barrier integrity was determined by measurement of the apical-to-basolateral flux of a fluorescent marker [fluorescein sulfonic acid (FSA; 200μg/mL; 478Da)] by the formula of FSA clearance (nl/h/cm<sup>2</sup>) = Fab/([FSA]a)×S) [<xref ref-type="bibr" rid="pone.0194867.ref030">30</xref>]. Fab is the apical-to-basolateral flux of FSA (light units/h), [FSA]a is the concentration at baseline (light units/nl) and S is the surface area (0.3cm<sup>2</sup>). Higher FSA represents more severe caco-2 monolayer mucosal dysfunction. Additionally, <italic>mRNA/</italic>protein expression levels in the caco-2 lysates were measured.</p>
</sec>
<sec id="sec013">
<title><italic>In vitro</italic> effects of calcitriol on NASH-V-CM/TNFα-induced lipogenesis on lean-V rat hepatocytes</title>
<p>After isolation and standard preparation [<xref ref-type="bibr" rid="pone.0194867.ref029">29</xref>,<xref ref-type="bibr" rid="pone.0194867.ref031">31</xref>], lean-V rat hepatocytes (5×10<sup>5</sup>) were cultured with buffer, TNFα, or NASH-V-CM in the presence or absence of 1,25(OH)<sub>2</sub>D<sub>3</sub> for 36 hours. Following this, oil red O stain-based measurement of intracellular TG accumulation was carried out. In parallel, expression of various <italic>mRNA/</italic>protein in corresponding cell lysates was measured.</p>
<sec id="sec014">
<title>Statistical analysis</title>
<p>Data were analyzed using Graphpad Prism 4 (GraphPad Software, San Diego, CA) and expressed as means±S.D. Statistical significance for each group was determined using one-way ANOVA with <italic>post hoc</italic> multiple comparisons being performed using the Newman-Keuls test. When the criteria for parametric testing were validated, Mann-Whitney U-tests were performed. <italic>P</italic> value less than 0.05 was considered significant.</p>
</sec>
</sec>
</sec>
<sec id="sec015" sec-type="results">
<title>Results</title>
<p>Notably, 14 weeks of high-fat diet (HFD) feeding induced typical NASH histology as well as high ALT, AST, fasting glucose and triglyceride levels in NASH-V rats (<xref ref-type="fig" rid="pone.0194867.g001">Fig 1A</xref>, <xref ref-type="table" rid="pone.0194867.t001">Table 1</xref>). Significantly, the HE stain-assessed NAS scores, O-red-oil stain-assessed hepatic steatosis, hepatic triglyceride levels, body weight, and liver weight in NASH-V rats were higher than those in the lean-V rats (<xref ref-type="fig" rid="pone.0194867.g001">Fig 1A–1C</xref>, <xref ref-type="table" rid="pone.0194867.t001">Table 1</xref>).</p>
<fig id="pone.0194867.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0194867.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Chronic calcitriol treatment ameliorates hepatic steatosis and improved inflammatory profiles of monocytes.</title>
<p>H-E (a) and O-red oil staining (b) for hepatic steatosis. (c) hepatic triglyceride content and (d) cytokines levels in the cell lysates of various rat monocytes. (e) A representative flow cytometric histogram/dot plots of the cytokines/cytokine receptors of NASH-V-rat monocytes. (f) A bar graph of the flow cytometry-assessed cytokines/cytokine receptors of monocytes from various rats. <sup>†</sup><italic>P</italic>&lt;0.05, <sup>††</sup> <italic>P</italic>&lt;0.01 <italic>vs</italic>. lean-V group; *<italic>P</italic>&lt; 0.05, **<italic>P</italic>&lt;0.01 <italic>vs</italic>. NASH-V group.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0194867.g001" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0194867.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0194867.t001</object-id>
<label>Table 1</label> <caption><title>Basal characteristics of all rats.</title></caption>
<alternatives>
<graphic id="pone.0194867.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0194867.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify"/>
<th align="justify">Lean-V (n = 6)</th>
<th align="justify">Lean-vit. D (n = 6)</th>
<th align="justify">NASH-V (n = 9)</th>
<th align="justify">NASH-vit.D (n = 9)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify">Body weight (gram)</td>
<td align="justify">399±17</td>
<td align="justify">406±19</td>
<td align="justify">508±49<xref ref-type="table-fn" rid="t001fn003"><sup>††</sup></xref></td>
<td align="justify">462±30<xref ref-type="table-fn" rid="t001fn004">*</xref></td>
</tr>
<tr>
<td align="justify">Liver weight (gram)</td>
<td align="justify">15.7±1.3</td>
<td align="justify">17.9±1.8</td>
<td align="justify">37.1±1.2<xref ref-type="table-fn" rid="t001fn002"><sup>†</sup></xref></td>
<td align="justify">29.3±2.5<xref ref-type="table-fn" rid="t001fn004">*</xref></td>
</tr>
<tr>
<td align="justify">[fasting glucose] (mg/dL)</td>
<td align="justify">107.5±4.8</td>
<td align="justify">98.7±10.5</td>
<td align="justify">227.3 ±8.1<xref ref-type="table-fn" rid="t001fn002"><sup>†</sup></xref></td>
<td align="justify">165.4±9.2<xref ref-type="table-fn" rid="t001fn004">*</xref></td>
</tr>
<tr>
<td align="justify">[Triglyceride] (mg/dL)</td>
<td align="justify">59±4</td>
<td align="justify">50±10</td>
<td align="justify">199±18<xref ref-type="table-fn" rid="t001fn003"><sup>††</sup></xref></td>
<td align="justify">95±8<xref ref-type="table-fn" rid="t001fn005">**</xref></td>
</tr>
<tr>
<td align="justify">[aspartate aminotransferase] (AST, U/L)</td>
<td align="justify">49.6±5.1</td>
<td align="justify">48.5±4.3</td>
<td align="justify">111.4±3.5<xref ref-type="table-fn" rid="t001fn002"><sup>†</sup></xref></td>
<td align="justify">80.7± 8.6<xref ref-type="table-fn" rid="t001fn004">*</xref></td>
</tr>
<tr>
<td align="justify">[alanine aminotransferase] (ALT, U/L)</td>
<td align="justify">45.8±6.2</td>
<td align="justify">35.9±4.7</td>
<td align="justify">91.7±6.2<xref ref-type="table-fn" rid="t001fn003"><sup>††</sup></xref></td>
<td align="justify">70.7±3.9<xref ref-type="table-fn" rid="t001fn005">**</xref></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>Data were expressed as mean ±SD;</p></fn>
<fn id="t001fn002"><p><sup>†</sup><italic>P</italic>&lt;0.05,</p></fn>
<fn id="t001fn003"><p><sup>††</sup> <italic>P</italic>&lt;0.01 vs. lean-V rat's data;</p></fn>
<fn id="t001fn004"><p>* <italic>P</italic> &lt;0.05,</p></fn>
<fn id="t001fn005"><p>**<italic>P</italic>&lt;0.01 <italic>vs</italic>. NASH-V rat's data.</p></fn>
</table-wrap-foot>
</table-wrap>
<sec id="sec016">
<title>Correction of the hypo-vitaminemia D inhibits systemic/portal endotoxemia and systemic inflammatory profiles</title>
<p>Compared to lean-V rats, NASH-V rats were found to have higher levels of plasma TNFα, LBP, and plasma/portal endotoxin, as well as lower levels of plasma/intestinal calcitriol (<xref ref-type="table" rid="pone.0194867.t002">Table 2</xref>). Compared to the NASH-V group, restoration of plasma calcitriol levels in NASH-vit.D rats by 10 weeks of calcitriol treatment was accompanied by the suppression of plasma and portal endotoxin levels as well as the reduction of LBP and TNFα levels (<xref ref-type="table" rid="pone.0194867.t002">Table 2</xref>). Higher TNFα, TNFRI, NFκB, and TLR4 expression in NASH-V rat monocytes than in the lean-V group was observed and this was accompanied by lower vitamin D receptor (VDR) expression (<xref ref-type="fig" rid="pone.0194867.g001">Fig 1D–1F</xref>). Significantly, 10 weeks of calcitriol treatment suppressed the TNFα, TNFRI, NFκB and TLR4 expression and normalized VDR expression in the NASH rat monocytes (<xref ref-type="fig" rid="pone.0194867.g001">Fig 1D–1F</xref>). Nonetheless, no significant difference in the aforementioned markers was found when lean-V and lean-vit.D groups were compared.</p>
<table-wrap id="pone.0194867.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0194867.t002</object-id>
<label>Table 2</label> <caption><title>Various pathogenic markers in all rats.</title></caption>
<alternatives>
<graphic id="pone.0194867.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0194867.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify"/>
<th align="justify">Lean-V (n = 6)</th>
<th align="justify">Lean-vit. D (n = 6)</th>
<th align="justify">NASH-V (n = 9)</th>
<th align="justify">NASH-vit.D (n = 9)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify">[Calcitriol, 1,25(OH)<sub>2</sub>D<sub>3</sub>, pg/mL]</td>
<td align="justify">12.1±0.4</td>
<td align="justify">14.8±1.3</td>
<td align="justify">4.6±1.1<xref ref-type="table-fn" rid="t002fn003"><sup>††</sup></xref></td>
<td align="justify">11.9±2.1<xref ref-type="table-fn" rid="t002fn005">**</xref></td>
</tr>
<tr>
<td align="justify">[Endotoxin, EU/mL]</td>
<td align="justify">3.8±0.4</td>
<td align="justify">3.2±0.2</td>
<td align="justify">17.8±2.3<xref ref-type="table-fn" rid="t002fn003"><sup>††</sup></xref></td>
<td align="justify">8.8±1.1<xref ref-type="table-fn" rid="t002fn005">**</xref></td>
</tr>
<tr>
<td align="justify">Portal venous endotoxin levels [EU/mL]</td>
<td align="justify">4.1±0.08</td>
<td align="justify">3.7±0.05</td>
<td align="justify">19.5±1.1<xref ref-type="table-fn" rid="t002fn003"><sup>††</sup></xref></td>
<td align="justify">9.4±0.9<xref ref-type="table-fn" rid="t002fn005">**</xref></td>
</tr>
<tr>
<td align="justify">[TNFα, pg/mL]</td>
<td align="justify">4.8±1.1</td>
<td align="justify">4.1± 0.7</td>
<td align="justify">22.1±3.5<xref ref-type="table-fn" rid="t002fn003"><sup>††</sup></xref></td>
<td align="justify">13.9±2.1<xref ref-type="table-fn" rid="t002fn004">*</xref></td>
</tr>
<tr>
<td align="justify">[LPS binding protein, LBP, ng/mL]</td>
<td align="justify">309±13</td>
<td align="justify">252±28</td>
<td align="justify">4239±547<xref ref-type="table-fn" rid="t002fn003"><sup>††</sup></xref></td>
<td align="justify">2520±438<xref ref-type="table-fn" rid="t002fn005">**</xref></td>
</tr>
<tr>
<td align="justify">Bacterial-translocation (BT rate, %) positive culture of mesenteric lymph node (MLN)</td>
<td align="justify">0</td>
<td align="justify">0</td>
<td align="justify">6/9 (67%)<xref ref-type="table-fn" rid="t002fn003"><sup>††</sup></xref></td>
<td align="justify">3/9(33%) <xref ref-type="table-fn" rid="t002fn004">*</xref></td>
</tr>
<tr>
<td align="justify">Intestinal calcitriol [1,25(OH)<sub>2</sub>D<sub>3</sub>, pg/gram]</td>
<td align="justify">80±11</td>
<td align="justify">82±7</td>
<td align="justify">41±8<xref ref-type="table-fn" rid="t002fn003"><sup>††</sup></xref></td>
<td align="justify">69±10 <xref ref-type="table-fn" rid="t002fn004">*</xref></td>
</tr>
<tr>
<td align="justify">Intestinal caspase-3 activity (fold changes compared to lean-V)</td>
<td align="justify">1</td>
<td align="justify">0.9±0.2</td>
<td align="justify">4.3±0.5 <xref ref-type="table-fn" rid="t002fn002"><sup>†</sup></xref></td>
<td align="justify">2.9±0.4<xref ref-type="table-fn" rid="t002fn004">*</xref></td>
</tr>
<tr>
<td align="justify">Hepatic TNFα levels (pg/mg protein)</td>
<td align="justify">25±1</td>
<td align="justify">22±4</td>
<td align="justify">66±3<xref ref-type="table-fn" rid="t002fn002"><sup>†</sup></xref></td>
<td align="justify">42±7<xref ref-type="table-fn" rid="t002fn004">*</xref></td>
</tr>
<tr>
<td align="justify">Hepatic MCP-1 levels (pg/mg protein)</td>
<td align="justify">220±11</td>
<td align="justify">198±23</td>
<td align="justify">519±16<xref ref-type="table-fn" rid="t002fn003"><sup>††</sup></xref></td>
<td align="justify">403±38<xref ref-type="table-fn" rid="t002fn004">*</xref></td>
</tr>
<tr>
<td align="justify">Hepatic IL-6 levels (pg/mg protein)</td>
<td align="justify">27±3</td>
<td align="justify">21±8</td>
<td align="justify">58±17<xref ref-type="table-fn" rid="t002fn002"><sup>†</sup></xref></td>
<td align="justify">42±19<xref ref-type="table-fn" rid="t002fn004">*</xref></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>Data were expressed as mean ±SD;</p></fn>
<fn id="t002fn002"><p><sup>†</sup><italic>P</italic>&lt;0.05,</p></fn>
<fn id="t002fn003"><p><sup>††</sup> <italic>P</italic>&lt;0.01 vs. lean-V rat's data;</p></fn>
<fn id="t002fn004"><p>* <italic>P</italic> &lt;0.05,</p></fn>
<fn id="t002fn005"><p>**<italic>P</italic>&lt;0.01 <italic>vs</italic>. NASH-V rat's data.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec017">
<title>Chronic calcitriol treatment suppresses intestinal hyper-permeability and intestinal pathogenic signals in NASH rats</title>
<p>In NASH-V rats, intestinal hyper-permeability (DX-4000-FITC and fecal albumin-based assays) and down-regulated tight-junction proteins (ZO-1 and occludin) expressions were associated with the decreased intestinal VDR and increased intestinal TNFα, TNFRI, caspase-7, Bax and MLCK levels (<xref ref-type="fig" rid="pone.0194867.g002">Fig 2A–2D</xref>). Furthermore, the aforementioned intestinal abnormalities were significantly suppressed in NASH-V rats (Figs <xref ref-type="fig" rid="pone.0194867.g002">2</xref> and <xref ref-type="fig" rid="pone.0194867.g003">3A</xref>).</p>
<fig id="pone.0194867.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0194867.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Chronic calcitriol treatment normalizes intestinal VDR expression and improves intestinal hyper-permeability in NASH rats.</title>
<p>DX-4000 FITC-based (a) and fecal albumin-based (b) assessment of intestinal permeability. The expression of various proteins (c) and <italic>mRNAs</italic> (d) in intestines from different groups of rat; AUC: area under curves; <sup>†</sup><italic>P</italic>&lt;0.05, <sup>††</sup> <italic>P</italic>&lt;0.01 <italic>vs</italic>. lean-V group; *<italic>P</italic>&lt; 0.05, **<italic>P</italic>&lt;0.01 <italic>vs</italic>. NASH-V group.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0194867.g002" xlink:type="simple"/>
</fig>
<fig id="pone.0194867.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0194867.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Chronic calcitriol treatment improved intestinal inflammation in NASH rats.</title>
<p>The expression of various proteins (a) in the intestines from various different groups of rat and the flow-cytometry-based analysis of macrophage infiltration in the same rat (b) small intestine. <sup>†</sup><italic>P</italic>&lt;0.05, <sup>††</sup> <italic>P</italic>&lt;0.01 <italic>vs</italic>. lean-V group; *<italic>P</italic>&lt; 0.05, **<italic>P</italic>&lt;0.01 <italic>vs</italic>. NASH-V group.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0194867.g003" xlink:type="simple"/>
</fig>
<p>Significantly, intestinal hyper-permeability was associated with an abundance of <italic>Bacteroides-Prevotella</italic> and a reduction in <italic>Lactobacillus</italic> (↓89%) and <italic>Bifidobacterium</italic> (↓79%) numbers in NASH-V rats. However, the improvement in intestinal hyperpermeability in NASH-vit. D rats was not accompanied by the reversal of rat gut microbiota changes (<xref ref-type="table" rid="pone.0194867.t003">Table 3</xref>).</p>
<table-wrap id="pone.0194867.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0194867.t003</object-id>
<label>Table 3</label> <caption><title>Qantification of total number of bacterial cells of the intestinal flora in cecal content.</title></caption>
<alternatives>
<graphic id="pone.0194867.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0194867.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify"/>
<th align="justify">Lean-V</th>
<th align="justify">Lean-vit. D</th>
<th align="justify">NASH-V</th>
<th align="justify">NASH-vit.D</th>
</tr>
</thead>
<tbody>
<tr>
<td align="justify"><italic>Lactobacillus</italic> spp. (cells/g cecal content)</td>
<td align="justify">7.1×10<sup>8</sup>±2.9×10<sup>8</sup></td>
<td align="justify">8.5×10<sup>8</sup>±3.6×10<sup>8</sup></td>
<td align="justify">2.3×10<sup>7</sup>±0.49×10<sup>7</sup><xref ref-type="table-fn" rid="t003fn002"><sup>†</sup></xref></td>
<td align="justify">2.9×10<sup>7</sup>±0.86×10<sup>7</sup></td>
</tr>
<tr>
<td align="justify"><italic>Bifidobacterium</italic> spp. (cells/g cecal content)</td>
<td align="justify">5.3×10<sup>6</sup>±1.4×10<sup>6</sup></td>
<td align="justify">6.8×10<sup>6</sup>±0.9×10<sup>6</sup></td>
<td align="justify">1.4×10<sup>4</sup>±0.57×10<sup>4</sup><xref ref-type="table-fn" rid="t003fn003"><sup>††</sup></xref></td>
<td align="justify">6.6×10<sup>4</sup>±0.89×10<sup>4</sup></td>
</tr>
<tr>
<td align="justify"><italic>Bacteroides-Prevotella</italic> spp. (cells/g cecal content)</td>
<td align="justify">4.9×10<sup>8</sup>±0.43×10<sup>8</sup></td>
<td align="justify">1.1×10<sup>8</sup>±0.23×10<sup>8</sup></td>
<td align="justify">2.9×10<sup>9</sup>±0.55×10<sup>9</sup><xref ref-type="table-fn" rid="t003fn002"><sup>†</sup></xref></td>
<td align="justify">1.9×10<sup>8</sup>±0.27×10<sup>8</sup></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p>Data were expressed as mean ±SD;</p></fn>
<fn id="t003fn002"><p><sup>†</sup><italic>P</italic>&lt;0.05,</p></fn>
<fn id="t003fn003"><p><sup>††</sup> <italic>P</italic>&lt;0.01 vs. lean-V rat's cecal content.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec018">
<title>Intestinal hyper-permeability parallels to the portal endotoxemia and tissue inflammation in NASH rats</title>
<p>Notably, the intestinal hyper-permeability was associated with portal endotoxemia and increased hepatic/MAT/intestinal macrophage infiltration, inflammation and corresponding cytokines levels (IL-6, MCP-1, <italic>F4/80</italic>, TNFα, <italic>NFκBp65</italic>, TNFRI and TLR4) in NASH-V rats (Tables <xref ref-type="table" rid="pone.0194867.t001">1</xref> and <xref ref-type="table" rid="pone.0194867.t002">2</xref>, Figs <xref ref-type="fig" rid="pone.0194867.g002">2C</xref>, <xref ref-type="fig" rid="pone.0194867.g002">2D</xref>, <xref ref-type="fig" rid="pone.0194867.g003">3</xref> and <xref ref-type="fig" rid="pone.0194867.g004">4</xref>).</p>
<fig id="pone.0194867.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0194867.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Chronic calcitriol treatment suppresses mesenteric adipose tissue (MAT) inflammation of NASH rats.</title>
<p>(a) A flow-cytometry-based analysis of macrophage infiltration in rat MAT. (b) The cytokines levels in the supernatant of MAT-derived adipocytes collected from different groups of rats. (c) The expression levels of <italic>mRNA</italic>s in the cell lysates of lean-V rat adipocytes after various treatments. (d) The peak levels of cytokine releases in the supernatant of NASH-V rat adipocytes after various treatments; †<italic>P</italic>&lt;0.05, †† <italic>P</italic>&lt;0.01 <italic>vs</italic>. lean-V/buffer group; *<italic>P</italic>&lt; 0.05, **<italic>P</italic>&lt;0.01 vs. NASH-V-CM/TNFα group.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0194867.g004" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec019">
<title>Chronic calcitriol treatment suppresses MAT inflammation and reduces the inflammatory profiles of NASH-V rat adipocytes</title>
<p>Compared to the lean-V group, a significant increase in the number of infiltrated macrophages in MAT was noted in the NASH-V group (<xref ref-type="fig" rid="pone.0194867.g004">Fig 4A</xref>). In addition, the releases of TNFα, MCP-1 and IL-6 from MAT-derived adipocytes was higher in the NASH-vit. D group than that in the NASH-V group (<xref ref-type="fig" rid="pone.0194867.g004">Fig 4B</xref>). In lean-V rat adipocytes cultures, NASH-V-CM and TNFα induce the release of aforementioned cytokines and up-regulated the <italic>TNFR1</italic>/<italic>NFκB</italic> expressions in cell lysates, which were dose-dependently abolished by vitamin D co-incubation (<xref ref-type="fig" rid="pone.0194867.g004">Fig 4C and 4D</xref>).</p>
</sec>
<sec id="sec020">
<title>Acute calcitriol incubation prevents NASH-V-CM/TNFα-induced caco-2 monolayer mucosal dysfunction</title>
<p><xref ref-type="fig" rid="pone.0194867.g005">Fig 5A and 5B</xref> revealed that NASH-V-CM and TNFα induced barrier dysfunction and caused a decrease in the IF-evaluated ZO-1 stained positive area of caco-2 monolayers. These changes were accompanied by down-regulation of VDR, ZO-1 and occludin expression, as well as up-regulation of <italic>caspase-3</italic>, <italic>cascapse-7</italic>, <italic>Bax</italic>, and MLCK expression in caco-2 cell lysates (<xref ref-type="fig" rid="pone.0194867.g005">Fig 5C and 5D</xref>). Dose-dependently, incubation with vitamin D normalized the aforementioned NASH-V-CM and TNFα-induced changes in the caco-2 cells culture system (<xref ref-type="fig" rid="pone.0194867.g005">Fig 5</xref>).</p>
<fig id="pone.0194867.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0194867.g005</object-id>
<label>Fig 5</label>
<caption>
<title><italic>In vitro</italic> effects of calcitriol on the NASH-V-CM and TNFα-induced mucosal dysfunction in caco-2 cells.</title>
<p>(a,b) The <italic>in vitro</italic> effects of various treatments on caco-2 monolayer mucosal dysfunction and IF-stained ZO-1 expression. (c,d) protein and <italic>mRNA</italic> levels in the cell lysates of caco-2 monolayer cells after various treatments. <sup>†</sup><italic>P</italic>&lt;0.05, <sup>††</sup> <italic>P</italic>&lt;0.01 <italic>vs</italic>. lean-V group; *<italic>P</italic>&lt; 0.05, **<italic>P</italic>&lt;0.01 <italic>vs</italic>. NASH-V-CM group.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0194867.g005" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec021">
<title>Acute calcitriol incubation prevents NASH-V-CM/TNFα-induced lean-V rat hepatocytes' lipogenesis</title>
<p>Compared to the buffer group, NASH-V-CM and TNFα (25ng/mL) significantly increased the intracellular triglyceride content of lean-V rat hepatocytes (<xref ref-type="fig" rid="pone.0194867.g006">Fig 6A</xref>). Furthermore, the HFD-V-CM and TNFα-induced lean-V rat hepatocyte lipogenesis was accompanied by up-regulation of <italic>TNFR1</italic>/NFκBp65 as well as lipogenic signals in the cell lysates (<xref ref-type="fig" rid="pone.0194867.g006">Fig 6B and 6C</xref>). Notably, incubation with vitamin D dose-dependently reversed the aforementioned NASH-V-CM and TNFα-induced changes in the lean-V rat hepatocyte culture system (<xref ref-type="fig" rid="pone.0194867.g006">Fig 6A–6C</xref>).</p>
<fig id="pone.0194867.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0194867.g006</object-id>
<label>Fig 6</label>
<caption>
<title><italic>In vitro</italic> effects of calcitriol on the NASH-V-CM and TNFα-induced lipogenesis in lean-V rat hepatocytes.</title>
<p>(a) representative micrographs of intracellular lipogenesis in lean-V rat hepatocytes after various different treatments. (b,c) The cytokines levels, lipogenic protein/<italic>mRNA</italic> levels in the cell lysates of lean-V rat hepatocytes after various treatments. <sup>†</sup><italic>P</italic>&lt;0.05, <sup>††</sup> <italic>P</italic>&lt;0.01 <italic>vs</italic>. buffer-group; *<italic>P</italic>&lt; 0.05, **<italic>P</italic>&lt;0.01 <italic>vs</italic>. NASH-V-CM-group/TNFα-group.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0194867.g006" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec022" sec-type="conclusions">
<title>Discussion</title>
<p>Increased TNFα-TNFR1 gene expression and elevated soluble TNFα levels are well-recognized pathogenic factors for NASH development [<xref ref-type="bibr" rid="pone.0194867.ref032">32</xref>,<xref ref-type="bibr" rid="pone.0194867.ref033">33</xref>]. Vitamin D can suppress TNF-α and IL-6 production by activated-monocytes in type 2 diabetic patients [<xref ref-type="bibr" rid="pone.0194867.ref034">34</xref>]. In cultured peritoneal macrophages of patients undergoing peritoneal dialysis, vitamin D dose-dependently inhibit LPS-stimulated TNFα release [<xref ref-type="bibr" rid="pone.0194867.ref035">35</xref>]. Our study reveals that the cytokines (TNF-α, IL-6, and MCP-1) released from NASH-V rat monocytes is higher than those in the lean-V group. Significantly, in our study, chronic vitamin D treatment inhibited the cytokines levels in monocytes of NASH-vit. D rats compared to those in NASH-V rats. TNFα-mediated inflammatory responses are mainly mediated by TNFR1 [<xref ref-type="bibr" rid="pone.0194867.ref036">36</xref>]. So, it is reasonable to observe that TNFα-related effects were found to be mediated by the TNFR1-NFκB pathway in monocytes and the tissues of NASH-V rats.</p>
<p>Vitamin D and vitamin D receptors (VDRs) are important regulators of intestinal inflammation [<xref ref-type="bibr" rid="pone.0194867.ref018">18</xref>,<xref ref-type="bibr" rid="pone.0194867.ref019">19</xref>,<xref ref-type="bibr" rid="pone.0194867.ref031">31</xref>,<xref ref-type="bibr" rid="pone.0194867.ref037">37</xref>]. In particular, vitamin D and VDR deficiency exacerbates experimental inflammatory bowel disease (IBD) [<xref ref-type="bibr" rid="pone.0194867.ref018">18</xref>,<xref ref-type="bibr" rid="pone.0194867.ref019">19</xref>,<xref ref-type="bibr" rid="pone.0194867.ref037">37</xref>]. It is reported that VDR gene-knocknout mice develop severe intestinal inflammation in experimental models of IBD [<xref ref-type="bibr" rid="pone.0194867.ref037">37</xref>–<xref ref-type="bibr" rid="pone.0194867.ref039">39</xref>]. <italic>In vitro</italic> studies have shown that vitamin D protects against dextran sodium sulfate (DSS)-induced disruption of intestinal epithelial tight junctions [<xref ref-type="bibr" rid="pone.0194867.ref040">40</xref>,<xref ref-type="bibr" rid="pone.0194867.ref041">41</xref>]. In our NASH rats, the intestine VDR expression was negatively correlated with the animals' intestinal TNFα levels, intestinal hyper-permeability and tight junction protein expression and these could be corrected by chronic vitamin D treatment.</p>
<p>Binding of TNFα to TNFR, which activates myosin light chain kinase (MLCK) and NFκB in intestinal epithelial cells can result in epithelial mucosal barrier dysfunction [<xref ref-type="bibr" rid="pone.0194867.ref040">40</xref>–<xref ref-type="bibr" rid="pone.0194867.ref042">42</xref>]. Intestinal MLCK over-expression has been reported in patients with ulcerative colitis and Crohn’s disease [<xref ref-type="bibr" rid="pone.0194867.ref043">43</xref>]. Up-regulated MLCK and NFκB can induce apoptosis and rearrangement of tight junction proteins, including occludin and ZO-1 [<xref ref-type="bibr" rid="pone.0194867.ref040">40</xref>,<xref ref-type="bibr" rid="pone.0194867.ref041">41</xref>–<xref ref-type="bibr" rid="pone.0194867.ref043">43</xref>]. In our NASH rats receiving chronic vitamin D treatment, down-regulation of intestinal TNFα-TNFR1-NFκB signals prevented intestinal apoptotic activity and preserved the integrity of the intestinal mucosal barrier by decreasing MLCK expression and normalizing tight-junction protein expression. In our caco-2 cell system, TNFα and the supernatant of cultured NASH-V rat monocytes could induce monolayer mucosal dysfunction and the corresponding pathogenic signals, which could be inhibited by vitamin D co-incubation.</p>
<p>In experimental colitis models, 1,25(OH)<sub>2</sub>vitamin D<sub>3</sub> has been found to suppress intestinal mucosal injury, decrease intestinal inflammation and maintain the integrity of the intestinal mucosal barrier [<xref ref-type="bibr" rid="pone.0194867.ref038">38</xref>,<xref ref-type="bibr" rid="pone.0194867.ref039">39</xref>]. A negative correlation has been noted between serum vitamin D and bacterial-translocation in HIV/hepattis C virus co-infected patients [<xref ref-type="bibr" rid="pone.0194867.ref044">44</xref>]. High LBP levels and MLN positive culture rates are representative markers for increased bacterial-translocation [<xref ref-type="bibr" rid="pone.0194867.ref044">44</xref>,<xref ref-type="bibr" rid="pone.0194867.ref045">45</xref>]. In our NASH rats receiving vitamin D treatment, normalization of plasma/tissue calcitriol and VDR levels was accompanied by a decrease in the MLN positive culture rate and in plasma LBP levels. In addition to bacterial-translocation, alteration in gut microbiota is known to be involved in the progression of NASH [<xref ref-type="bibr" rid="pone.0194867.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0194867.ref013">13</xref>,<xref ref-type="bibr" rid="pone.0194867.ref014">14</xref>]. Modulation of gut microbiota ameliorates obesity-associated impaired intestinal mucosal intergrity and bacterial-translocation in rats [<xref ref-type="bibr" rid="pone.0194867.ref013">13</xref>,<xref ref-type="bibr" rid="pone.0194867.ref014">14</xref>]. In our study, the lack of an effect of chronic vitamin D treatment on the gut microbiota indicates that the benefits of chronic vitamin D treatment in our NASH-vit.D rats involved other mechanisms.</p>
<p>In our lean rat mesenteric adipose tissue (MAT)-derived adipocytes, TNFα and the supernatant of cultured NASH-V rat monocytes induced cytokines release, which could be inhibited by vitamin D co-incubation. The blood and lymphatic vessels draining the gut are embedded in MAT [<xref ref-type="bibr" rid="pone.0194867.ref046">46</xref>]. In NASH animals with endotoxemia, there is a positive regulatory loop between intestinal mucosal barrier dysfunction and MAT inflammation [<xref ref-type="bibr" rid="pone.0194867.ref006">6</xref>,<xref ref-type="bibr" rid="pone.0194867.ref008">8</xref>]. In our NASH rats, vitamin D treatment-related correction of intestinal mucosal barrier dysfunction was accompanied by an improvement in MAT inflammation and a reduction in endotoxemia. In fact, a causal link has been reported between the HFD-induced gut inflammation and the activated inflammatory profile in MAT adjacent to the inflamed intestine [<xref ref-type="bibr" rid="pone.0194867.ref010">10</xref>]. In inflamed adipose tissue, vitamin D can suppress the TNFα and NFκB-mediated cytokines release [<xref ref-type="bibr" rid="pone.0194867.ref047">47</xref>,<xref ref-type="bibr" rid="pone.0194867.ref048">48</xref>]. In NAFLD patients, vitamin D deficiency has been reported to increase the risk of NASH via activation of NFκB signals [<xref ref-type="bibr" rid="pone.0194867.ref017">17</xref>,<xref ref-type="bibr" rid="pone.0194867.ref049">49</xref>]. So, it is reasonable to observe in our NASH rats that macrophage infiltration, inflammation, and TNFα-NFκB-mediated cytokines release in gut and adipose tissues were simultaneously inhibited by chronic vitamin D treatment.</p>
<p>Blood from the portal vein drains to the liver and thus, the liver is exposed to relatively high concentrations of TNFα and IL-6 released by the inflammed gut and MAT [<xref ref-type="bibr" rid="pone.0194867.ref050">50</xref>]. Both <italic>in vivo</italic> and <italic>in vitro</italic> studies have reported that TNFα and IL-6 can exacerbate hepatic steatosis [<xref ref-type="bibr" rid="pone.0194867.ref051">51</xref>–<xref ref-type="bibr" rid="pone.0194867.ref053">53</xref>]. TNFα can activate NFκB and stimulate IL-6 production from hepatocytes [<xref ref-type="bibr" rid="pone.0194867.ref054">54</xref>]. Vitamin D treatment suppresses hepatic lipogenesis by down-regulation of lipogenic signals [<xref ref-type="bibr" rid="pone.0194867.ref023">23</xref>,<xref ref-type="bibr" rid="pone.0194867.ref025">25</xref>,<xref ref-type="bibr" rid="pone.0194867.ref055">55</xref>]. In our study, chronic vitamin D treatment decrease hepatic steatosis by suppressing the levels of TNFα, NFκB and IL-6 in NASH rat livers. Additionally, in an <italic>in vitro</italic> study, the suppression of TNFα-TNFR1-NFκB signaling and corresponding lipogenesis by vitamin D co-incubation was observed in lean rat hepatocytes.</p>
<p>In conclusion, our study suggests that systemic/portal endotoxemia, intestinal inflammation, intestinal hyper-permeability, together with up-regulation of TNFα-mediated signaling contribute to down-regulation of VDR expression in monocytes as well as within the intestine of NASH rats. Furthermore, intestinal hyper-permeability exacerbates bacterial translocation to mesenteric lymph nodes and mesenteric adipose tissue inflammation; this subsequently leads to TNFα-TNFR1-NFκB-mediated hepatic steatosis in NASH rats. Intriguingly, the intestinal VDR deficiencies as well as the related TNFα-TNFR1-NFκB-mediated gut/adipose/liver abnormalities can be effectively attenuated by chronic calcitriol treatment in NASH animals. So, in addition to diet control and exercise, chronic use of vitamin D may be a promising strategy for the improvement of NASH.</p>
</sec>
<sec id="sec023">
<title>Supporting information</title>
<supplementary-material id="pone.0194867.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0194867.s001" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Primer of rat gene used for quantitative realtime PCR analysis.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0194867.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0194867.s002" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Chronic calcitriol treatment dose-dependently inhibits hepatic steatosis and serum/intestinal TNFα levels of NASH-V rats.</title>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0194867.s003" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0194867.s003" xlink:type="simple">
<label>S1 File</label>
<caption>
<title>Supplement materials and methods.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0194867.s004" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0194867.s004" xlink:type="simple">
<label>S2 File</label>
<caption>
<title>Laboratory protocols of the procedure of isolation of adipocytes from rat mesenteric adipose tissue (MAT) in protocols.io.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0194867.s005" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0194867.s005" xlink:type="simple">
<label>S3 File</label>
<caption>
<title>Data of this study.</title>
<p>(XLSX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We especially thank Yun-Ru Wang, Fan-Yi Jhan, Che-Jui Chang and Yen-Ling Lin for their excellent technical supports.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0194867.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Van der Bruggen</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Nijenhuis</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>van Raaij</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Verhoef</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>van Asbeck</surname> <given-names>BS</given-names></name>. <article-title>Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the Raf-1/MEK1-MEK2/ERK1-ERK2 pathway</article-title>. <source>Infect Immun</source>. <year>1999</year>:<volume>67</volume>(<issue>8</issue>); <fpage>3824</fpage>–<lpage>3829</lpage>. <object-id pub-id-type="pmid">10417144</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Poniachik</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Csendes</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Díaz</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Rojas</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Burdiles</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Maluenda</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Increased production of IL-1alpha and TNF-alpha in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease</article-title>. <source>Cytokine</source>. <year>2006</year>:<volume>33</volume>(<issue>5</issue>); <fpage>252</fpage>–<lpage>257</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cyto.2006.02.006" xlink:type="simple">10.1016/j.cyto.2006.02.006</ext-link></comment> <object-id pub-id-type="pmid">16564703</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jiang</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Chi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Qiu</surname> <given-names>X</given-names></name>, <etal>et al</etal>. <article-title>Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease</article-title>. <source>Sci Rep</source>. <year>2015</year>:<volume>5</volume>;<fpage>8096</fpage>–<lpage>8102</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/srep08096" xlink:type="simple">10.1038/srep08096</ext-link></comment> <object-id pub-id-type="pmid">25644696</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leppkes</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Roulis</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Neurath</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Kollias</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Becker</surname> <given-names>C</given-names></name>. <article-title>Pleiotropic functions of TNF-alpha in the regulation of the intestinal epithelial response to inflammation</article-title>. <source>Int Immunol</source>. <year>2014</year>:<volume>26</volume>(<issue>9</issue>);<fpage>509</fpage>–<lpage>515</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/intimm/dxu051" xlink:type="simple">10.1093/intimm/dxu051</ext-link></comment> <object-id pub-id-type="pmid">24821262</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wigg</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Roberts-Thomson</surname> <given-names>IC</given-names></name>, <name name-style="western"><surname>Dymock</surname> <given-names>RB</given-names></name>, <name name-style="western"><surname>McCarthy</surname> <given-names>PJ</given-names></name>, <name name-style="western"><surname>Grose</surname> <given-names>RH</given-names></name>, <name name-style="western"><surname>Cummins</surname> <given-names>AG</given-names></name>. <article-title>The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis</article-title>. <source>Gut</source>. <year>2001</year>:<volume>48</volume>(<issue>2</issue>);<fpage>206</fpage>–<lpage>211</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/gut.48.2.206" xlink:type="simple">10.1136/gut.48.2.206</ext-link></comment> <object-id pub-id-type="pmid">11156641</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>F</given-names></name>. <article-title>Blockade of hypoxia-inducible factor-1α by YC-1 attenuates interferon-γ and tumor necrosis factor-α-induced intestinal epithelial barrier dysfunction</article-title>. <source>Cytokine</source>. <year>2011</year>:<volume>56</volume>(<issue>3</issue>);<fpage>581</fpage>–<lpage>588</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cyto.2011.08.023" xlink:type="simple">10.1016/j.cyto.2011.08.023</ext-link></comment> <object-id pub-id-type="pmid">21890376</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miele</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Valenza</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>La Torre</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Montalto</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Cammarota</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Ricci</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease</article-title>. <source>Hepatology</source>. <year>2009</year>:<volume>49</volume>(<issue>6</issue>);<fpage>1877</fpage>–<lpage>1887</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/hep.22848" xlink:type="simple">10.1002/hep.22848</ext-link></comment> <object-id pub-id-type="pmid">19291785</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lam</surname> <given-names>YY</given-names></name>, <name name-style="western"><surname>Ha</surname> <given-names>CW</given-names></name>, <name name-style="western"><surname>Campbell</surname> <given-names>CR</given-names></name>, <name name-style="western"><surname>Mitchell</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Dinudom</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Oscarsson</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice</article-title>. <source>PLoS One</source>. <year>2012</year>:<volume>7</volume>(<issue>3</issue>);<fpage>e34233</fpage>–<lpage>e34232</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0034233" xlink:type="simple">10.1371/journal.pone.0034233</ext-link></comment> <object-id pub-id-type="pmid">22457829</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brun</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Castagliuolo</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Di Leo</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Buda</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Pinzani</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Palù</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2007</year>:<volume>292</volume>(<issue>2</issue>);<fpage>G518</fpage>–<lpage>G525</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpgi.00024.2006" xlink:type="simple">10.1152/ajpgi.00024.2006</ext-link></comment> <object-id pub-id-type="pmid">17023554</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Lelliott</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Håkansson</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Ploj</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Tuneld</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Verolin-Johansson</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Intestinal, adipose, and liver inflammation in diet-induced obese mice</article-title>. <source>Metabolism</source>. <year>2008</year>:<volume>57</volume>(<issue>12</issue>);<fpage>1704</fpage>–<lpage>1710</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.metabol.2008.07.029" xlink:type="simple">10.1016/j.metabol.2008.07.029</ext-link></comment> <object-id pub-id-type="pmid">19013294</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brandl</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Schnabl</surname> <given-names>B</given-names></name>. <article-title>Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?</article-title> <source>Expert Rev Gastroenterol Hepatol</source>. <year>2015</year>:<volume>9</volume>(<issue>8</issue>);<fpage>1069</fpage>–<lpage>1076</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1586/17474124.2015.1057122" xlink:type="simple">10.1586/17474124.2015.1057122</ext-link></comment> <object-id pub-id-type="pmid">26088524</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gäbele</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Dostert</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Hofmann</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Wiest</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Schölmerich</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Hellerbrand</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH</article-title>. <source>J Hepatol</source>. <year>2011</year>:<volume>55</volume>(<issue>6</issue>);<fpage>1391</fpage>–<lpage>1399</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jhep.2011.02.035" xlink:type="simple">10.1016/j.jhep.2011.02.035</ext-link></comment> <object-id pub-id-type="pmid">21703208</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jiang</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Gao</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Tian</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Lei</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Bi</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Apple-derived pectin modulates gut microbiota, improves gut barrier function, and attenuates metabolic endotoxemia in rats with diet-induced obesity</article-title>. <source>Nutrients</source>. <year>2016</year>:<volume>8</volume>(<issue>3</issue>);<fpage>126</fpage>–<lpage>145</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/nu8030126" xlink:type="simple">10.3390/nu8030126</ext-link></comment> <object-id pub-id-type="pmid">26938554</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Bose</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>GC</given-names></name>, <name name-style="western"><surname>Hong</surname> <given-names>SU</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>JE</given-names></name>, <etal>et al</etal>. <article-title>Flos lonicera ameliorates obesity and associated endotoxemia in rats through modulation of gut permeability and intestinal microbiota</article-title>. <source>PLoS One</source>. <year>2014</year>:<volume>9</volume>(<issue>1</issue>);<fpage>e86117</fpage>–<lpage>e86130</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0086117" xlink:type="simple">10.1371/journal.pone.0086117</ext-link></comment> <object-id pub-id-type="pmid">24475077</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Müller</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Haahr</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Diamant</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Rieneck</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Kharazmi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Bendtzen</surname> <given-names>K</given-names></name>. <article-title>1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level</article-title>. <source>Cytokine</source>. <year>1992</year>:<volume>4</volume>(<issue>6</issue>);<fpage>506</fpage>–<lpage>512</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/1043-4666(92)90012-G" xlink:type="simple">10.1016/1043-4666(92)90012-G</ext-link></comment> <object-id pub-id-type="pmid">1337987</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Peterson</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Heffernan</surname> <given-names>ME</given-names></name>. <article-title>Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women</article-title>. <source>J Inflamm</source>. <year>2008</year>:<volume>5</volume>;<fpage>10</fpage>–<lpage>18</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1476-9255-5-10" xlink:type="simple">10.1186/1476-9255-5-10</ext-link></comment> <object-id pub-id-type="pmid">18652680</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Targher</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Bertolini</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Scala</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Cigolini</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Zenari</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Falezza</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease</article-title>. <source>Nutr Metab Cardiovasc Dis</source>. <year>2007</year>:<volume>17</volume>(<issue>7</issue>);<fpage>517</fpage>–<lpage>524</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.numecd.2006.04.002" xlink:type="simple">10.1016/j.numecd.2006.04.002</ext-link></comment> <object-id pub-id-type="pmid">16928437</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Du</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Shi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Ge</surname> <given-names>X</given-names></name>, <etal>et al</etal>. <article-title>MicroRNA-346 mediates tumor necrosis factor α-induced down-regulation of gut epithelial vitamin D receptor in inflammatory bowel diseases</article-title>. <source>Inflamm Bowel Dis</source>. <year>2014</year>:<volume>20</volume>(<issue>11</issue>);<fpage>1910</fpage>–<lpage>1918</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/MIB.0000000000000158" xlink:type="simple">10.1097/MIB.0000000000000158</ext-link></comment> <object-id pub-id-type="pmid">25192497</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>YC</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Du</surname> <given-names>J</given-names></name>. <article-title>Critical roles of intestinal epithelial vitamin D receptor signaling in controlling gut mucosal inflammation</article-title>. <source>J Steroid Biochem Mol Biol</source>. <year>2015</year>:<volume>148</volume>;<fpage>179</fpage>–<lpage>183</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jsbmb.2015.01.011" xlink:type="simple">10.1016/j.jsbmb.2015.01.011</ext-link></comment> <object-id pub-id-type="pmid">25603468</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nakano</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Cheng</surname> <given-names>YF</given-names></name>, <name name-style="western"><surname>Lai</surname> <given-names>CY</given-names></name>, <name name-style="western"><surname>Hsu</surname> <given-names>LW</given-names></name>, <name name-style="western"><surname>Chang</surname> <given-names>YC</given-names></name>, <name name-style="western"><surname>Deng</surname> <given-names>JY</given-names></name>, <etal>et al</etal>. <article-title>Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats</article-title>. <source>J Hepatol</source>. <year>2011</year>:<volume>55</volume>(<issue>2</issue>);<fpage>415</fpage>–<lpage>425</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jhep.2010.11.028" xlink:type="simple">10.1016/j.jhep.2010.11.028</ext-link></comment> <object-id pub-id-type="pmid">21184788</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Roth</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Elfers</surname> <given-names>CT</given-names></name>, <name name-style="western"><surname>Figlewicz</surname> <given-names>DP</given-names></name>, <name name-style="western"><surname>Melhorn</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Morton</surname> <given-names>GJ</given-names></name>, <name name-style="western"><surname>Hoofnagle</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation</article-title>. <source>Hepatology</source>. <year>2012</year>:<volume>55</volume>(<issue>4</issue>);<fpage>1103</fpage>–<lpage>11</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/hep.24737" xlink:type="simple">10.1002/hep.24737</ext-link></comment> <object-id pub-id-type="pmid">21994008</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Han</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Cui</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>You</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Piao</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Jin</surname> <given-names>G</given-names></name>. <article-title>A role of 1,25(OH)2D3 supplementation in rats with nonalcoholic steatohepatitis induced by choline-deficient diet</article-title>. <source>Nutr Metab Cardiovasc Dis</source>. <year>2015</year>:<volume>25</volume>(<issue>6</issue>);<fpage>556</fpage>–<lpage>61</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.numecd.2015.02.011" xlink:type="simple">10.1016/j.numecd.2015.02.011</ext-link></comment> <object-id pub-id-type="pmid">25843661</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>XJ</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>BW</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Xia</surname> <given-names>MZ</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>YH</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>CQ</given-names></name>, <etal>et al</etal>. <article-title>Vitamin D Deficiency Attenuates High-Fat Diet-Induced Hyperinsulinemia and Hepatic Lipid Accumulation in Male Mice</article-title>. <source>Endocrinology</source>. <year>2015</year>:<volume>156</volume>(<issue>6</issue>);<fpage>2103</fpage>–<lpage>2113</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/en.2014-2037" xlink:type="simple">10.1210/en.2014-2037</ext-link></comment> <object-id pub-id-type="pmid">25774554</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chang</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>Y</given-names></name>. <article-title>Vitamin D insufficiency exacerbates adipose tissue macrophage infiltration and decreases AMPK/SIRT1 activity in obese rats</article-title>. <source>Nutrients</source>. <year>2017</year>:<volume>9</volume>(<issue>4</issue>);<fpage>338</fpage>–<lpage>352</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/nu9040338" xlink:type="simple">10.3390/nu9040338</ext-link></comment> <object-id pub-id-type="pmid">28353634</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Lv</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Ning</surname> <given-names>C</given-names></name>,<name name-style="western"><surname>Yang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Zhu</surname> <given-names>J</given-names></name>. <article-title>Preventive and therapeutic effect of 1,25-dihydroxyvitamin D3 on non-alcoholic steatohepatitis of rats</article-title>. <source>Exp Ther Med</source>. <year>2016</year>:<volume>11</volume>(<issue>6</issue>);<fpage>2284</fpage>–<lpage>2292</lpage>.</mixed-citation></ref>
<ref id="pone.0194867.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Manna</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Achari</surname> <given-names>AE</given-names></name>, <name name-style="western"><surname>Jain</surname> <given-names>SK</given-names></name>. <article-title>Vitamin D supplementation inhibits oxidative stress and upregulate SIRT1/AMPK/GLUT4 cascade in high glucose-treated 3T3L1 adipocytes and in adipose tissue of high fat diet-fed diabetic mice</article-title>. <source>Arch Biochem Biophys</source>. <year>2017</year>:<volume>615</volume>;<fpage>22</fpage>–<lpage>34</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.abb.2017.01.002" xlink:type="simple">10.1016/j.abb.2017.01.002</ext-link></comment> <object-id pub-id-type="pmid">28063949</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Drori</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Rotnemer-Golinkin</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Avni</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Drori</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Danay</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Levanon</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift</article-title>. <source>BMC Gastroenterol</source>. <year>2017</year>:<volume>17</volume>(<issue>1</issue>);<fpage>130</fpage>–<lpage>139</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12876-017-0688-4" xlink:type="simple">10.1186/s12876-017-0688-4</ext-link></comment> <object-id pub-id-type="pmid">29179679</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kilkenny</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Browne</surname> <given-names>WJ</given-names></name>, <name name-style="western"><surname>Cuthill</surname> <given-names>IC</given-names></name>, <name name-style="western"><surname>Emerson</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>. <article-title>Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research</article-title>. <source>PLoS Biol</source>. <year>2010</year>:<volume>8</volume>;<fpage>e1000412</fpage>–<lpage>e1000416</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pbio.1000412" xlink:type="simple">10.1371/journal.pbio.1000412</ext-link></comment> <object-id pub-id-type="pmid">20613859</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duarte</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Wei</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Paulino</surname> <given-names>PVR</given-names></name>, <name name-style="western"><surname>Du</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Jiang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Zan</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Isolation of mature adipocytes and stromal vascular cells under adverse sampling conditions</article-title>. <source>J Metabolic Synd</source>. <year>2012</year>:<volume>1</volume>;<fpage>4</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4172/2167-0943.1000112" xlink:type="simple">10.4172/2167-0943.1000112</ext-link></comment></mixed-citation></ref>
<ref id="pone.0194867.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Unno</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Menconi</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Salzman</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hagen</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Ge</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Hyperpermeability and ATP depletion induced by chronic hypoxia or glycolytic inhibition in Caco-2B Be monolayers</article-title>. <source>Am J Physiol</source>. <year>1996</year>:<volume>270</volume>;<fpage>G1010</fpage>–<lpage>1021</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpgi.1996.270.6.G1010" xlink:type="simple">10.1152/ajpgi.1996.270.6.G1010</ext-link></comment> <object-id pub-id-type="pmid">8764209</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cantorna</surname> <given-names>MT</given-names></name>. <article-title>Mechanisms underlying the effects of vitamin D on the immune system</article-title>. <source>Proc Nutr Soc</source>. <year>2010</year>:<volume>69</volume>;<fpage>286</fpage>–<lpage>289</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1017/S0029665110001722" xlink:type="simple">10.1017/S0029665110001722</ext-link></comment> <object-id pub-id-type="pmid">20515520</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Crespo</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Cayon</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Fernandez-Gil</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Hernandez-Guerra</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Mayorga</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Domínguez-Díez</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients</article-title>. <source>Hepatology</source>. <year>2001</year>:<volume>34</volume>;<fpage>1158</fpage>–<lpage>1163</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1053/jhep.2001.29628" xlink:type="simple">10.1053/jhep.2001.29628</ext-link></comment> <object-id pub-id-type="pmid">11732005</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tomita</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Tamiya</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Ando</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Ohsumi</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Chiyo</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Mizutani</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice</article-title>. <source>Gut</source>. <year>2006</year>:<volume>55</volume>(<issue>3</issue>);<fpage>415</fpage>–<lpage>424</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/gut.2005.071118" xlink:type="simple">10.1136/gut.2005.071118</ext-link></comment> <object-id pub-id-type="pmid">16174657</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Giulietti</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>van Etten</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Overbergh</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Stoffels</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Bouillon</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Mathieu</surname> <given-names>C</given-names></name>. <article-title>Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory</article-title>. <source>Diabetes Res Clin Pract</source>. <year>2007</year>:<volume>77</volume>(<issue>1</issue>);<fpage>47</fpage>–<lpage>57</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.diabres.2006.10.007" xlink:type="simple">10.1016/j.diabres.2006.10.007</ext-link></comment> <object-id pub-id-type="pmid">17112620</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cohen</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Douvdevani</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Chaimovitz</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Shany</surname> <given-names>S</given-names></name>. <article-title>Regulation of TNF-alpha by 1alpha, 25-dihydroxyvitamin D3 in human macrophages from CAPD patients</article-title>. <source>Kidney Int</source>. <year>2001</year>:<volume>59</volume>(<issue>1</issue>); <fpage>69</fpage>–<lpage>75</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1046/j.1523-1755.2001.00467.x" xlink:type="simple">10.1046/j.1523-1755.2001.00467.x</ext-link></comment> <object-id pub-id-type="pmid">11135059</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Devin</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yamaoka</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Karin</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>Zg</given-names></name>. <article-title>The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF</article-title>. <source>Mol Cell Biol</source>. <year>2001</year>:<volume>21</volume>(<issue>12</issue>);<fpage>3986</fpage>–<lpage>3994</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/MCB.21.12.3986-3994.2001" xlink:type="simple">10.1128/MCB.21.12.3986-3994.2001</ext-link></comment> <object-id pub-id-type="pmid">11359906</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Froicu</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Weaver</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Wynn</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>McDowell</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Welsh</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Cantorna</surname> <given-names>MT</given-names></name>. <article-title>A crucial role for the vitamin D receptor in experimental inflammatory bowel disease</article-title>. <source>Mol Endocrinol</source> <year>2003</year>:<volume>17</volume>;<fpage>2386</fpage>–<lpage>2392</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/me.2003-0281" xlink:type="simple">10.1210/me.2003-0281</ext-link></comment> <object-id pub-id-type="pmid">14500760</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kong</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Musch</surname> <given-names>MW</given-names></name>, <name name-style="western"><surname>Ning</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2008</year>:<volume>294</volume>;<fpage>G208</fpage>–<lpage>216</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpgi.00398.2007" xlink:type="simple">10.1152/ajpgi.00398.2007</ext-link></comment> <object-id pub-id-type="pmid">17962355</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhao</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice</article-title>. <source>BMC Gastroenterol</source>. <year>2012</year>:<volume>12</volume>;<fpage>57</fpage>–<lpage>70</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-230X-12-57" xlink:type="simple">10.1186/1471-230X-12-57</ext-link></comment> <object-id pub-id-type="pmid">22647055</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Su</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Nalle</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Shen</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Turner</surname> <given-names>ES</given-names></name>, <name name-style="western"><surname>Singh</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Breskin</surname> <given-names>LA</given-names></name>, <etal>et al</etal>. <article-title>TNFR2 activates MLCK-dependent tight junction dys-regulation to cause apoptosis-mediated barrier loss and experimental colitis</article-title>. <source>Gastroenterology</source>. <year>2013</year>:<volume>145</volume>(<issue>2</issue>);<fpage>407</fpage>–<lpage>415</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1053/j.gastro.2013.04.011" xlink:type="simple">10.1053/j.gastro.2013.04.011</ext-link></comment> <object-id pub-id-type="pmid">23619146</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ma</surname> <given-names>TY</given-names></name>, <name name-style="western"><surname>Iwamoto</surname> <given-names>GK</given-names></name>, <name name-style="western"><surname>Hoa</surname> <given-names>NT</given-names></name>, <name name-style="western"><surname>Akotia</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Pedram</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Boivin</surname> <given-names>MA</given-names></name>, <etal>et al</etal>. <article-title>TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source>. <year>2004</year>:<volume>286</volume>(<issue>3</issue>);<fpage>G367</fpage>–<lpage>376</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpgi.00173.2003" xlink:type="simple">10.1152/ajpgi.00173.2003</ext-link></comment> <object-id pub-id-type="pmid">14766535</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Feng</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Teitelbaum</surname> <given-names>DH</given-names></name>. <article-title>Tumour necrosis factor-α-induced loss of intestinal barrier function requires TNFR1 and TNFR2 signalling in a mouse model of total parenteral nutrition</article-title>. <source>J Physiol</source>. <year>2013</year>:<volume>591</volume>(<issue>Pt 15</issue>):<fpage>3709</fpage>–<lpage>3723</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1113/jphysiol.2013.253518" xlink:type="simple">10.1113/jphysiol.2013.253518</ext-link></comment> <object-id pub-id-type="pmid">23753529</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Blair</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Kane</surname> <given-names>SV</given-names></name>, <name name-style="western"><surname>Clayburgh</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Turner</surname> <given-names>JR</given-names></name>. <article-title>Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease</article-title>. <source>Lab Invest</source>. <year>2006</year>:<volume>86</volume>(<issue>2</issue>);<fpage>191</fpage>–<lpage>201</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/labinvest.3700373" xlink:type="simple">10.1038/labinvest.3700373</ext-link></comment> <object-id pub-id-type="pmid">16402035</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>García-Álvarez</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Berenguer</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Jiménez-Sousa</surname> <given-names>MÁ</given-names></name>, <name name-style="western"><surname>Vázquez-Morón</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Carrero</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Gutiérrez-Rivas</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Optimal vitamin D plasma levels are associated with lower bacterial DNA translocation in HIV/hepatitis C virus coinfected patients</article-title>. <source>AIDS</source>. <year>2016</year>:<volume>30</volume>(<issue>7</issue>);<fpage>1069</fpage>–<lpage>1074</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/QAD.0000000000001007" xlink:type="simple">10.1097/QAD.0000000000001007</ext-link></comment> <object-id pub-id-type="pmid">27032111</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gonzalez-Quintela</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Alonso</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Campos</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Vizcaino</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Loidi</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Gude</surname> <given-names>F</given-names></name>. <article-title>Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity</article-title>. <source>PLoS One</source>. <year>2013</year>:<volume>8</volume>(<issue>1</issue>);<fpage>e54600</fpage>–<lpage>e54607</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0054600" xlink:type="simple">10.1371/journal.pone.0054600</ext-link></comment> <object-id pub-id-type="pmid">23349936</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Trayhurn</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Beattie</surname> <given-names>JH</given-names></name>. <article-title>Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ</article-title>. <source>Proc Nutr Soc</source>. <year>2001</year>:<volume>60</volume>(<issue>3</issue>);<fpage>329</fpage>–<lpage>339</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1079/PNS200194" xlink:type="simple">10.1079/PNS200194</ext-link></comment> <object-id pub-id-type="pmid">11681807</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ding</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Wilding</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Bing</surname> <given-names>C</given-names></name>. <article-title>1,25-dihydroxyvitamin D3 protects against macrophage-induced activation of NFκB and MAPK signalling and chemokine release in human adipocytes</article-title>. <source>PLoS One</source>. <year>2013</year>:<volume>8</volume>(<issue>4</issue>);<fpage>e61707</fpage>–<lpage>61720</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0061707" xlink:type="simple">10.1371/journal.pone.0061707</ext-link></comment> <object-id pub-id-type="pmid">23637889</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gao</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Trayhurn</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Bing</surname> <given-names>C</given-names></name>. <article-title>1,25-Dihydroxyvitamin D3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes</article-title>. <source>Int J Obes</source>. <year>2013</year>:<volume>37</volume>(<issue>3</issue>);<fpage>357</fpage>–<lpage>365</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ijo.2012.53" xlink:type="simple">10.1038/ijo.2012.53</ext-link></comment> <object-id pub-id-type="pmid">22508334</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nelson</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Roth</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Wilson</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Yates</surname> <given-names>KP</given-names></name>, <name name-style="western"><surname>Aouizerat</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Morgan-Stevenson</surname> <given-names>V</given-names></name>, <etal>et al</etal>. <article-title>Vitamin D deficiency is associated with increased risk of non-alcoholic steatohepatitis in adults with non-alcoholic fatty liver disease: possible role for MAPK and NF-κB?</article-title> <source>Am J Gastroenterol</source>. <year>2016</year>:<volume>111</volume>(<issue>6</issue>);<fpage>852</fpage>–<lpage>863</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ajg.2016.51" xlink:type="simple">10.1038/ajg.2016.51</ext-link></comment> <object-id pub-id-type="pmid">27002799</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Amar</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Chabo</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Waget</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Klopp</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Vachoux</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Bermúdez-Humarán</surname> <given-names>LG</given-names></name>, <etal>et al</etal>. <article-title>Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of Type 2 diabetes: molecular mechanisms and probiotic treatment</article-title>. <source>EMBO Mol Med</source>. <year>2011</year>:<volume>3</volume>;<fpage>559</fpage>–<lpage>572</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/emmm.201100159" xlink:type="simple">10.1002/emmm.201100159</ext-link></comment> <object-id pub-id-type="pmid">21735552</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Feingold</surname> <given-names>KR</given-names></name>, <name name-style="western"><surname>Grunfeld</surname> <given-names>C</given-names></name>. <article-title>Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat <italic>in vivo</italic></article-title>. <source>J Clin Invest</source>. <year>1987</year>:<volume>80</volume>(<issue>1</issue>);<fpage>184</fpage>–<lpage>190</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI113046" xlink:type="simple">10.1172/JCI113046</ext-link></comment> <object-id pub-id-type="pmid">3597772</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grunfeld</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Dinarello</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Feingold</surname> <given-names>KR</given-names></name>. <article-title>Tumor necrosis factor-alpha, interleukin-1, and interferon alpha stimulate triglyceride synthesis in HepG2 cells</article-title>. <source>Metabolism</source>. <year>1991</year>:<volume>40</volume>(<issue>9</issue>);<fpage>894</fpage>–<lpage>898</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/0026-0495(91)90062-2" xlink:type="simple">10.1016/0026-0495(91)90062-2</ext-link></comment> <object-id pub-id-type="pmid">1654497</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vida</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Gavito</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Pavón</surname> <given-names>FJ</given-names></name>, <name name-style="western"><surname>Bautista</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Serrano</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Chronic administration of recombinant IL-6 up-regulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice</article-title>. <source>Dis Model Mech</source>. <year>2015</year>:<volume>8</volume>(<issue>7</issue>);<fpage>721</fpage>–<lpage>731</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/dmm.019166" xlink:type="simple">10.1242/dmm.019166</ext-link></comment> <object-id pub-id-type="pmid">26035386</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shimizu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Mitomo</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Watanabe</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Okamoto</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Yamamoto</surname> <given-names>K</given-names></name>. <article-title>Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines</article-title>. <source>Mol Cell Biol</source>. <year>1990</year>:<volume>10</volume>;<fpage>561</fpage>–<lpage>568</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/MCB.10.2.561" xlink:type="simple">10.1128/MCB.10.2.561</ext-link></comment> <object-id pub-id-type="pmid">2405250</object-id></mixed-citation></ref>
<ref id="pone.0194867.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kang</surname> <given-names>EJ</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>An</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Kwon</surname> <given-names>HS</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>BC</given-names></name>, <etal>et al</etal>. <article-title>The effects of vitamin D3 on lipogenesis in the liver and adipose tissue of pregnant rats</article-title>. <source>Int J Mol Med</source>. <year>2015</year>:<volume>36</volume>(<issue>4</issue>);<fpage>1151</fpage>–<lpage>1158</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3892/ijmm.2015.2300" xlink:type="simple">10.3892/ijmm.2015.2300</ext-link></comment> <object-id pub-id-type="pmid">26239543</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>